医学
药物警戒
单克隆抗体
不利影响
抗体
药理学
免疫学
作者
Jee Myung Yang,Se Yong Jung,Min Seo Kim,Seung Won Lee,Dong Keon Yon,Jae Il Shin,Joo Yong Lee
标识
DOI:10.1016/j.ophtha.2024.07.008
摘要
To analyze cardiovascular and cerebrovascular adverse events (ADRs) after intravitreal anti-vascular endothelial growth factor (VEGF; aflibercept, bevacizumab, brolucizumab, and ranibizumab) treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI